BiomarkersHumans2,928 individualsCohort study

Speech age gaps track dementia phenotypes and biological aging

In 2,928 individuals across five Latin American countries, speech age gaps tracked dementia diagnoses, brain age, social exposome, and epigenetic aging clocks.

Fig. 1. Study design. (A) We recruited 2928 participants from five Latin American countries (Argentina, Chile, Mexico, Peru, and Colombia), encompassing HCs and persons with MCI, AD, and both…
Open the figure at full size
Fig. 1. Study design. (A) We recruited 2928 participants from five Latin American countries (Argentina, Chile, Mexico, Peru, and Colombia), encompassing HCs and persons…Study design. (A) We recruited 2928 participants from five Latin American countries (Argentina, Chile, Mexico, Peru, and Colombia), encompassing HCs and persons with MCI, AD, and both non-language-dominant and language-dominant variants of frontotemporal dementia degeneration…Hernandez et al.

Science Advances

In a cross-sectional study of 2,928 human participants across five Latin American countries, researchers developed a speech-based biological aging clock. The cohort included healthy controls alongside individuals with mild cognitive impairment, Alzheimer's disease, and non-language or language-dominant frontotemporal dementia. Supervised models trained on multimodal acoustic and linguistic features estimated chronological age, yielding speech age gaps where positive values reflect older-appearing speech. Speech age gaps differentiated diagnostic groups, with healthy controls scoring lower than patient groups, and Alzheimer's disease scoring lower than frontotemporal dementia variants. These gaps associated with clinical and cognitive domains, structural and functional brain clocks, and social exposome. In Alzheimer's disease, speech age gaps correlated with phosphorylated tau (p-Tau217). The metric also correlated with epigenetic age clocks, including Retroclock and OMICmAge.

Why it matters

The results indicate that speech features capture cross-sectional, multilevel variation associated with biological aging and neurodegeneration. This approach may provide a scalable, low-cost biomarker candidate for aging studies in underrepresented global populations.

Caveats

The findings rely on cross-sectional data, which cannot capture dynamic, longitudinal changes in speech or disease progression. In addition, associations between speech age gaps and specific epigenetic clocks varied across diagnostic subgroups.

The paper

Speech clocks decode dementia phenotypes, social exposome, and biological aging